-
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
Nat Rev Cancer. 2006 Feb;6(2):107-16
PMID: 16491070
-
Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers.
J Anal Toxicol. 2006 Apr;30(3):187-95
PMID: 16803653
-
MGMT gene silencing and benefit from temozolomide in glioblastoma.
N Engl J Med. 2005 Mar 10;352(10):997-1003
PMID: 15758010
-
Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
Int J Mol Med. 2004 Nov;14(5):825-36
PMID: 15492852
-
Identification of methylated genes associated with aggressive bladder cancer.
PLoS One. 2010 Aug 23;5(8):e12334
PMID: 20808801
-
Risk of bladder cancer by source and type of tobacco exposure: a case-control study.
Int J Cancer. 1989 Oct 15;44(4):622-8
PMID: 2793235
-
A road map for those who don't know JAK-STAT.
Science. 2002 May 31;296(5573):1653-5
PMID: 12040185
-
A case-control study of smoking and bladder cancer risk: emergent patterns over time.
J Natl Cancer Inst. 2009 Nov 18;101(22):1553-61
PMID: 19917915
-
Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
Blood. 2010 Mar 25;115(12):2412-9
PMID: 20061560
-
Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation.
Int J Cancer. 2004 Jan 1;108(1):2-7
PMID: 14618608
-
The fundamental role of epigenetic events in cancer.
Nat Rev Genet. 2002 Jun;3(6):415-28
PMID: 12042769
-
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.
Cancer Res. 2005 Aug 15;65(16):7081-5
PMID: 16103055
-
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Life Sci. 2010 Jul 17;87(3-4):83-91
PMID: 20470789
-
Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.
PLoS One. 2009 Dec 21;4(12):e8357
PMID: 20027224
-
Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
J Cell Physiol. 2010 Oct;225(1):168-73
PMID: 20458733
-
Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
Exp Cell Res. 2010 May 15;316(9):1479-88
PMID: 20338164
-
A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).
Cancer Causes Control. 2002 Feb;13(1):83-90
PMID: 11899922
-
Aromatic amines and cancer.
Cancer Causes Control. 1997 May;8(3):346-55
PMID: 9498898
-
Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
Cancer Causes Control. 2004 Jun;15(5):465-72
PMID: 15286466
-
Erythropoietin in cancer: an update.
Curr Mol Med. 2008 Sep;8(6):481-91
PMID: 18781955
-
Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
Cancer Res. 2005 Nov 15;65(22):10170-3
PMID: 16288001
-
Focus on bladder cancer.
Cancer Cell. 2004 Aug;6(2):111-6
PMID: 15324694
-
ERK5 and the regulation of endothelial cell function.
Biochem Soc Trans. 2009 Dec;37(Pt 6):1254-9
PMID: 19909257
-
Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
Mol Vis. 2006 Aug 10;12:885-91
PMID: 16917481
-
Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.
Cell. 1986 Oct 10;47(1):3-10
PMID: 3489530
-
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer.
Carcinogenesis. 2007 Aug;28(8):1745-51
PMID: 17522068
-
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
Nat Clin Pract Urol. 2005 Oct;2(10):502-10
PMID: 16474624
-
High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer.
Nucleic Acids Res. 2006 Jan 23;34(2):555-63
PMID: 16432260
-
Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake.
PLoS Genet. 2010 Jul 29;6(7):e1001043
PMID: 20686660
-
Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.
Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):108-14
PMID: 17220338
-
Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2003 May;21(1):29-43
PMID: 12826031
-
Passive smoking in adulthood and cancer risk.
Am J Epidemiol. 1985 Jan;121(1):37-48
PMID: 3964991
-
Bladder cancer.
Lancet. 2009 Jul 18;374(9685):239-49
PMID: 19520422
-
Urinary excretion of mutagens in smokers of cigarettes with various tar and nicotine yields, black tobacco, and cigars.
Cancer Lett. 1987 Jan;34(1):103-12
PMID: 3802064
-
The global burden of urinary bladder cancer.
Scand J Urol Nephrol Suppl. 2008 Sep;(218):12-20
PMID: 19054893
-
High-throughput DNA methylation profiling using universal bead arrays.
Genome Res. 2006 Mar;16(3):383-93
PMID: 16449502
-
Nonsmoking-related arylamine exposure and bladder cancer risk.
Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7
PMID: 12814994
-
Prevention of bladder cancer.
N Engl J Med. 1999 May 6;340(18):1424-6
PMID: 10228196
-
Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
J Natl Cancer Inst. 2001 Mar 7;93(5):378-81
PMID: 11238699
-
Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Carcinogenesis. 2006 Jan;27(1):112-6
PMID: 15987713
-
Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.
Environ Health Perspect. 1998 Aug;106 Suppl 4:1047-50
PMID: 9703491
-
Human cancer from environmental pollutants: the epidemiological evidence.
Mutat Res. 2006 Sep 28;608(2):157-62
PMID: 16843042
-
T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing.
Trends Mol Med. 2010 Feb;16(2):77-87
PMID: 20122868
-
Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Cancer Res. 2007 Aug 1;67(15):7095-105
PMID: 17671176
-
A mechanism for the initiation of allergen-induced T helper type 2 responses.
Nat Immunol. 2008 Mar;9(3):310-8
PMID: 18300366